Amgen (AMGN) Shares Outstanding (2009 - 2026)

Amgen has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $540.6 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.43% year-over-year to $540.6 million in Q2 2026; TTM through Jun 2026 was $540.6 million, a 0.43% change from a year earlier, with the FY2025 full-year figure at $538.8 million, changed 0.35% from the prior year.
• Shares Outstanding (Entity) was $540.6 million for Q2 2026 at Amgen, roughly flat from $539.7 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $540.6 million in Q2 2026, with the low at $533.5 million in Q3 2022.
• Average Shares Outstanding (Entity) over 5 years is $536.6 million, with a median of $536.6 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) slipped 7.14% in 2022, then advanced 0.45% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $534.0 million in 2022, then gained by 0.26% to $535.4 million in 2023, then gained by 0.28% to $536.9 million in 2024, then climbed by 0.35% to $538.8 million in 2025, then rose by 0.33% to $540.6 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $540.6 million (Q2 2026), $539.7 million (Q1 2026), and $538.8 million (Q4 2025), per Business Quant data.